BioPhorum introduces – the Speed to Clinic initiative

Broadcast date

Thu, Oct 20, 2022

 

Presented by

    Richard Alldread - CSL Behring
    Kartik Subramanian - Abbvie
    Nick Abu-Absi - Abbvie

 

Quick Description

Spurred on by lessons learned from the COVID-19 pandemic, combined with the ever-pressing need to streamline development and get medicines to clinics faster, BioPhorum has launched a Speed to Clinic initiative. As a priority topic for the industry, this has been met with much enthusiasm.

Details

Spurred on by lessons learned from the COVID-19 pandemic, combined with the ever-pressing need to streamline development and get medicines to clinics faster, BioPhorum has launched a Speed to Clinic initiative. As a priority topic for the industry, this has been met with much enthusiasm. We hear from Richard Alldread, Senior Director, Recombinant Product Development at CSL Behring Innovation GmbH, and Kartik Subramanian, Vice President, Science & Technology Biologics and Nick Abu-Absi, Director, Cell Culture Development both at AbbVie. They share their thoughts about the importance of this initiative, and outline how the industry is working together to solve the challenges of bringing medicines to clinic more quickly and effectively.

Speakers

Richard Alldread

Senior Director, Recombinant Product Development

CSL Behring

Kartik Subramanian

Vice President, Science & Technology Biologics

Abbvie

Nick Abu-Absi

Director, Cell Culture Development

Abbvie